Unknown

Dataset Information

0

A phase I study of carfilzomib for relapsed or refractory acute myeloid and acute lymphoblastic leukemia.

ABSTRACT:

SUBMITTER: Wartman LD 

PROVIDER: S-EPMC4888765 | biostudies-literature | 2016

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

A phase I study of carfilzomib for relapsed or refractory acute myeloid and acute lymphoblastic leukemia.

Wartman Lukas D LD   Fiala Mark A MA   Fletcher Theresa T   Hawkins Emily R ER   Cashen Amanda A   DiPersio John F JF   Jacoby Meagan A MA   Stockerl-Goldstein Keith E KE   Pusic Iskra I   Uy Geoffrey L GL   Westervelt Peter P   Vij Ravi R  

Leukemia & lymphoma 20151005 3

Similar Datasets

Unknown Phase 1b/2 study of blinatumomab in Japanese adults with relapsed/refractory acute lymphoblastic leukemia.
| S-EPMC7156857 | biostudies-literature
Unknown Isatuximab in combination with chemotherapy for pediatric patients with relapsed/refractory acute lymphoblastic leukemia or acute myeloid leukemia: The ISAKIDS study.
| S-EPMC12572944 | biostudies-literature
Unknown Treatment for Relapsed/Refractory Acute Myeloid Leukemia.
| S-EPMC8171365 | biostudies-literature
Unknown A phase 1 study of inotuzumab ozogamicin in pediatric relapsed/refractory acute lymphoblastic leukemia (ITCC-059 study).
| S-EPMC7995290 | biostudies-literature
Unknown Inotuzumab ozogamicin with bosutinib for relapsed or refractory Philadelphia chromosome positive acute lymphoblastic leukemia or lymphoid blast phase of chronic myeloid leukemia.
| S-EPMC9096877 | biostudies-literature
Unknown Phase II study of clofarabine in pediatric patients with refractory or relapsed acute myeloid leukemia.
| S-EPMC2744276 | biostudies-literature
Unknown A phase 1b study of venetoclax and alvocidib in patients with relapsed/refractory acute myeloid leukemia.
| S-EPMC10757832 | biostudies-literature
Unknown Phase I dose-escalation study of milademetan in patients with relapsed or refractory acute myeloid leukemia.
| S-EPMC9813109 | biostudies-literature
Unknown A Phase II Study of Coltuximab Ravtansine (SAR3419) Monotherapy in Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia.
| S-EPMC5557033 | biostudies-literature
Unknown Inotuzumab ozogamicin in adults with relapsed or refractory CD22-positive acute lymphoblastic leukemia: a phase 1/2 study.
| S-EPMC5728308 | biostudies-literature